UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
GemVax wins patent for personalized-tissue engineered vein technology
by Lee Han-soo
2017-12-19 16:16
Will Takeda, Dong-A ST benefit from new hypertension guideline?
by Nam Doo-hyun
2017-12-19 16:15
Allergan, Gedeon Richter prove efficacy of bipolar drug in pivotal trial
by Marian Chu
2017-12-19 15:26
New migraine drugs prepare to hit domestic market
by Lee Hye-seon
2017-12-19 15:26
AstraZeneca aims to make Tagrisso 1st-line lung cancer therapy
by Marian Chu
2017-12-19 14:36
라인
Boehringer Ingelheim Korea’s labor union protests early retirement program
by Nam Doo-hyun
2017-12-19 14:35
Daehwa Pharma launches clinical trial for breast cancer treatment
by Lee Han-soo
2017-12-18 16:59
Green Cross unveils non-clinical trial data for hemophilia A treatment
by Lee Han-soo
2017-12-18 15:12
Kwangdong punished for illegal ad of obesity drug
by Lee Hye-seon
2017-12-18 14:50
Yuhan’s chemo combo YH24931 more effective than immunotherapy alone
by Nam Doo-hyun
2017-12-18 11:51
라인
‘Postmenopausal women in 50s shouldn’t take phytoestrogen’
by Nam Doo-hyun
2017-12-18 10:49
3 Korean startups using AI to develop new drugs
by Marian Chu
2017-12-15 23:00
Medytox, Hugel compete in botulinum toxin market
by So Jae-hyeon
2017-12-15 15:12
Parkinson’s disease treatment Azilect in robust growth
by So Jae-hyeon
2017-12-15 11:36
Ildong, Abbot to tap rosuvastatin+ezetimibe combo market
by Lee Hye-seon
2017-12-14 15:01
라인
Koreans in their 20s most susceptible to hepatitis A: study
by Marian Chu
2017-12-13 18:18
MGmed to change name to Cancer Rop
by Marian Chu
2017-12-13 18:14
Syntekabio, CJ Healthcare agree to develop new drugs using AI
by Lee Han-soo
2017-12-13 17:17
Daewoong’s liver drug Ursa to enter US market
by So Jae-hyeon
2017-12-13 15:23
Janssen says its multiple myeloma drug combo halves death risk
by Marian Chu
2017-12-13 15:22
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top